Presenter: Yuehan Feng

Date: Tuesday, Sep 19, 2023, 11:45 AM – 1:00 PM
Session: PP03

Presenter: Ino Karemaker

Date: Monday, June 5
Topic area: Disease Biomarkers

Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related deaths worldwide. Although immunotherapy has improved the treatment of NSCLC, a significant number of patients still fail to respond or develop resistance.

Our new White Paper explains how advances in mass spectrometry can now unlock the potential of the plasma proteome, uncovering actionable insights that are essential for biomarker discovery and targeted drug development.

Poster MP 305 presented at ASMS 2022

Presenter: Christopher Below
Session: Ion Mobility: Applications I
Date: Monday, June 6

E-Poster #TP 005 presented at ASMS 2021

Presenter: Andrés Lanzós
Session: Biomarkers: Discovery
Date: Tuesday, November 2

The case study elaborates on the results of our pan-cancer proteomics study. We analyzed 180 plasma samples from lung, breast, colorectal, pancreatic, and prostate cancer using our next-generation TrueDiscovery™ platform to discover actionable biomarkers.

E-Poster #TP 025 presented at ASMS 2021

Presenter: Roland Bruderer
Session: Biomarkers: Discovery
Date: Tuesday, November 2

New: Spectronaut^® 19

Unlock Your Data's True Story

New: Spectronaut^® 19

Unlock Your Data's True Story

Learn More